Very early researchNot Yet RecruitingNCT07168291
What this trial is testing
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University 3